Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-trigger timing before oocyte retrieval in poor ovarian responders undergoing assisted reproduction
IRCT20120215009014N512Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of human chorionic gonadotropin and triptorelin in female infertility (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Ratio of oocytes retrieved to follicles >=14 mm. Started Jun 2024; status: completed.
02
Drugs
human chorionic gonadotropintriptorelin
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20120215009014N512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N512.